'Tmc125' diaporamas de présentation

DUET-1 and DUET-2: TMC125 versus placebo in treatment-experienced HIV-1-infected patients

491 views • 17 slides

Financial disclosures for Dr Hicks

Financial disclosures for Dr Hicks. Grant support, honoraria and/or advisory board from Abbott, Bristol-Myers Squibb, Boehringer-Ingelheim, Glaxo SmithKline, Merck, Pfizer, Tibotec, Monogram Biosciences, Gilead, Koronis.

301 views • 16 slides

Financial disclosures for Dr Hicks

Financial disclosures for Dr Hicks. Grant support, honoraria and/or advisory board from Abbott, Bristol-Myers Squibb, Boehringer-Ingelheim, Glaxo SmithKline, Merck, Pfizer, Tibotec, Monogram Biosciences, Gilead, Koronis.

165 views • 16 slides

Hicks C, et al. Oral presentation presented at IDSA 2007. Abst 1207

TTCA0064-07282-1. Pooled 24-week Results of DUET-1 and -2: Efficacy of TMC125 in Treatment-experienced HIV-1-infected Patients. C Hicks, P Cahn, J Leider, G Pialoux, M Peeters, J Vingerhoets and B Woodfall on behalf of the DUET-1 and DUET-2 study groups.

275 views • 14 slides